In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Angiodynamics Inc. (NASDAQ:ANGO) reported that Avista Capital Partners Gp, Llc. has picked up 2,333,008 of common stock as of 2017-04-14.
The acquisition brings the aggregate amount owned by Avista Capital Partners Gp, Llc. to a total of 2,333,008 representing a 6.3% stake in the company.
For those not familiar with the company, AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company’s Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company’s BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.
A glance at Angiodynamics Inc. (NASDAQ:ANGO)’s key stats reveals a current market capitalization of 558.82 Million based on 36.79 Million shares outstanding and a price at last close of $15.19 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-04-14, Kapusta picked up 1,000 at a purchase price of $13.90. This brings their total holding to 27,005 as of the date of the filing.
On the sell side, the most recent transaction saw Burgstahler unload 384,184 shares at a sale price of $16.00. This brings their total holding to 381,406.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Angiodynamics Inc. (NASDAQ:ANGO) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
